GDRX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
GDRX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GoodRx Holdings's gross profit for the three months ended in Mar. 2024 was $185.4 Mil. GoodRx Holdings's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was $701.5 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. GoodRx Holdings's gross profit for the three months ended in Mar. 2024 was $185.4 Mil. GoodRx Holdings's Revenue for the three months ended in Mar. 2024 was $197.9 Mil. Therefore, GoodRx Holdings's Gross Margin % for the quarter that ended in Mar. 2024 was 93.70%.
GoodRx Holdings had a gross margin of 93.70% for the quarter that ended in Mar. 2024 => Durable competitive advantage
During the past 6 years, the highest Gross Margin % of GoodRx Holdings was 97.58%. The lowest was 91.08%. And the median was 94.18%.
Warning Sign:
GoodRx Holdings Inc gross margin has been in long-term decline. The average rate of decline per year is -1.5%.
The historical data trend for GoodRx Holdings's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GoodRx Holdings Annual Data | |||||||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Gross Profit | Get a 7-Day Free Trial | 374.21 | 521.11 | 698.71 | 701.48 | 683.34 |
GoodRx Holdings Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Gross Profit | Get a 7-Day Free Trial | 167.29 | 173.34 | 161.24 | 181.47 | 185.41 |
For the Health Information Services subindustry, GoodRx Holdings's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, GoodRx Holdings's Gross Profit distribution charts can be found below:
* The bar in red indicates where GoodRx Holdings's Gross Profit falls into.
Gross Profit is the different between the sale prices and the cost of buying or producing the goods.
GoodRx Holdings's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as
Gross Profit (A: Dec. 2023 ) | = | Revenue | - | Cost of Goods Sold |
= | 750.265 | - | 66.925 | |
= | 683.3 |
GoodRx Holdings's Gross Profit for the quarter that ended in Mar. 2024 is calculated as
Gross Profit (Q: Mar. 2024 ) | = | Revenue | - | Cost of Goods Sold |
= | 197.88 | - | 12.468 | |
= | 185.4 |
Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $701.5 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
GoodRx Holdings's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as
Gross Margin % (Q: Mar. 2024 ) | = | Gross Profit (Q: Mar. 2024 ) | / | Revenue (Q: Mar. 2024 ) |
= | (Revenue - Cost of Goods Sold) | / | Revenue | |
= | 185.4 | / | 197.88 | |
= | 93.70 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
GoodRx Holdings (NAS:GDRX) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
GoodRx Holdings had a gross margin of 93.70% for the quarter that ended in Mar. 2024 => Durable competitive advantage
Thank you for viewing the detailed overview of GoodRx Holdings's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.
Scott Wagner | officer: Interim Chief Executive Office | C/O WILSON SONSINI GOODRICH AND ROSATI, 650 PAGE MILL ROAD, PALO ALTO CA 94304 |
Raj Beri | officer: Chief Operating Officer | C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA CA 90404 |
Romin Nabiey | officer: Chief Accounting Officer | C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA CA 90404 |
Andrew Slutsky | officer: President & Consumer | 233 WILSHIRE ROAD, SANTA MONICA CA 90410 |
Idea Men, Llc | 10 percent owner | 2701 OLYMPIC BOULEVARD, WEST BUILDING - SUITE 200, SANTA MONICA CA 90404 |
Karsten Voermann | officer: Chief Financial Officer | 233 WILSHIRE ROAD, SANTA MONICA CA 90410 |
Trevor Bezdek | director, officer: Co-CEO | 233 WILSHIRE ROAD, SANTA MONICA CA 90410 |
Abdiel Qualified Master Fund Lp | 10 percent owner | 90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016 |
Douglas Joseph Hirsch | director, officer: Co-CEO | 233 WILSHIRE ROAD, SANTA MONICA CA 90410 |
Babak Azad | officer: See Remarks | 233 WILSHIRE ROAD, SANTA MONICA CA 90410 |
Bansi Nagji | officer: President, Healthcare | MCKESSON CORPORATION, 6555 STATE HIGHWAY 161, IRVING TX 75039 |
Agnes Rey-giraud | director | |
Abdiel Capital Lp | 10 percent owner | C/O ABDIEL CAPITAL ADVISORS, LP, 90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016 |
Abdiel Capital Advisors, Lp | 10 percent owner | 90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016 |
Abdiel Capital Management, Llc | 10 percent owner | 90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016 |
From GuruFocus
By Jonathan Poland • 02-22-2023
By Business Wire • 10-19-2023
By Business Wire Business Wire • 04-12-2023
By Business Wire Business Wire • 05-25-2023
By Business Wire • 08-09-2023
By Business Wire • 01-10-2024
By GuruFocus Research • 11-09-2023
By Business Wire • 01-22-2024
By Business Wire • 09-13-2023
By Business Wire Business Wire • 01-31-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.